DNA gyrase from Staphylococcus aureus FDA 209P was partially purified by lysostaphin treatment, saturation with ammonium sulfate, and affinity chromatography on heparin-Sepharose and with a concentrator (Centricon 30). It was found to consist of two subunits: a and P. The ability of new quinolone antibacterial agents such as norfloxacin, ofloxacin, and ciprofioxacin to inhibit DNA gyrase activity and cell growth was investigated. The inhibitory effects of the new quinolones against the activity of S. aureus DNA gyrase were in parallel with their antibacterial activities. The 50% inhibitory doses of norfloxacin, ofloxacin, and ciplofloxacin were 0.34, 0.31, and 0.24 ,Ig/ml, respectively, while the 50% inhibitory doses of nalidixic acid and cinmoxacin, which were less active against S. aureus FDA 209P, were 100 ,Lg/ml or more.The DNA gyrases are topoisomerases which catalyze the supercoiling of relaxed covalently closed circular DNA, which is known to be coupled with the hydrolysis of ATP. The enzyme from Escherichia coli (topoisomerase II) is composed of two different subunits, A and B, which are encoded by the genes gyrA and gyrB, respectively (5, 7). The gyrA protein constitutes the target for nalidixic acid and oxolinic acid, and the gyrB protein is the target for novobiocin and coumermycin Al (6,8,9). The target of new quinolones, i.e., norfloxacin, ofloxacin, ciprofloxacin, and enoxacin, is subunit A; and these drugs exhibit marked inhibitory effects (18,21). Evidence has been provided that other gram-negative bacteria possess DNA gyrase and that it is inhibited by quinolones (14,19). In E. coli the active gyrase holoenzyme is a tetramer composed of two subunits, A2 and B2, which have molecular weights of 105,000 and 95,000, respectively (7). In regard to gram-positive bacteria, Orr and Staudenbauer (16) and Sugino and Bott (23) have reported the isolation of a gyrase from Bacillus subtilis, and Liu and Wang (12) have reported the isolation of a gyrase from Micrococcus luteus. Like E. coli, the M. luteus gyrase is a tetramer composed of two subunits, A and B, which have molecular weights of 115,000 and 87,000, respectively. The gyrases from these gram-positive bacteria catalyze the supercoiling of pBR322 DNA or ColEl DNA derived from E. coli (24). New quinolone derivatives such as norfloxacin, enoxacin, ofloxacin, ciprofloxacin, and fleroxacin with a broad spectrum of antibacterial activity against gram-positive and gram-negative bacteria have been developed recently (1,10,11,15,20 ATCC 25923 DNA gyrase and inhibition by quinolones, the newer and potent quinolones norfloxacin, ciplofloxacin, and ofloxacin (MICs, <2.0 ,ug/ml) do not inhibit supercoiling (50% inhibitory concentrations, ca. >200 , [g/ml). In this report, we describe the purification of DNA gyrase from S. aureus FDA 209P and the inhibitory effect of new quinolones on its activity.
MATERIALS AND METHODSBacterial strain and culture media. S. aureus FDA 209P, which is preserved at the Department of Microbiology, Kyoto Pharmaceutical University, Kyo...